Pulmovant is a clinical-stage biotechnology company focused on transforming the lives of patients with pulmonary diseases. Their investigational candidate, mosliciguat, is a potential first-in-class treatment for pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company has announced positive Phase 2 results and is advancing mosliciguat into Phase 3 trials. Pulmovant operates as part of the Roivant family of companies, leveraging collaboration and innovation. Roivant itself specializes in rapidly developing transformative medicines by launching specialized biopharmaceutical and health technology entities. Since 2014, Roivant has built over 20 'Vants', achieved numerous clinical and regulatory milestones, raised significant capital, and established global pharma partnerships. They also incubate discovery-stage companies and health technology startups.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior